Skip to main content

Advertisement

SpringerLink
Log in

Long-Term Results and Prognostic Factors in Resected Pancreatic Body and Tail Adenocarcinomas

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Background

Adenocarcinoma of the body and tail of the pancreas are more often than not inoperable to begin with. Factors predicting the prognosis in the resected tumors of pancreatic body and tail were analyzed.

Methods

Between 1989 and 2006, 43 patients with adenocarcinoma of the body and tail of the pancreas underwent resection at Chang Gung Memorial Hospital, Taoyuan, Taiwan. Univariate and multivariate analysis of clinicopathological factors affecting the prognosis were analyzed.

Results

Totally, 32 patients were available for the analysis. The median follow-up was 13.6 months (1.5–87.5 months). The median survival time was 14.2 months and the 1-, 3-, and 5-year survival rates were 58.1, 25.8, and 6.5 %, respectively. On univariate analysis, the factors which influenced the survival were tumor size >4 cm (p = 0.004), lymphatic invasion (p = 0.001), and positive resection margin (p = 0.030). On multivariate analysis, only the tumor size and the lymphatic invasion were independent prognostic factors.

Conclusion

Even after macroscopic curative resection, the prognosis remains poor for pancreatic body and tail adenocarcinoma. Early diagnosis is the key to achieving long-term survival. Newer effective adjuvant treatment after curative resection is needed to improve the survival

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fabre JM, Houry S, Manderscheid JC, Huguier M, Baume H. Surgery for left-sided pancreatic cancer. Br J Surg. 1996;83:1065–70.

    Article  PubMed  CAS  Google Scholar 

  2. Saltzman A, Horvitz A, Dyckman J. Survival for 25 years following partial pancreatectomy for carcinoma of the body of the pancreas. Mt Sinai J Med. 1987;54:427–8.

    PubMed  CAS  Google Scholar 

  3. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567–79.

    Article  PubMed  CAS  Google Scholar 

  4. Watanabe I, Sasaki S, Konishi M, Nakagohri T, Inoue K, Oda T, Kinoshita T. Onset symptoms and tumor locations as prognostic factors of pancreatic cancer. Pancreas. 2004;28:160–5.

    Article  PubMed  Google Scholar 

  5. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996;223:506–12.

    Article  PubMed  CAS  Google Scholar 

  6. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226:248–57.

    Article  PubMed  CAS  Google Scholar 

  7. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.

    Article  PubMed  Google Scholar 

  8. Cameron JL, Riall TS, Coleman J, et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10–5.

    Article  PubMed  Google Scholar 

  9. Cress RD, Yin D, Clarke L, et al. Survival among patients with adenocarcinoma of the pancreas: a population based study (United States). Cancer Causes Control. 2006;17:403–9.

    Article  PubMed  Google Scholar 

  10. Shoup M, Conlon KC, Klimstra D, Brennan MF. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified? J Gastrointest Surg. 2003;7:946–52.

    Article  PubMed  Google Scholar 

  11. Ozaki H, Kinoshita T, Kosuge T, Yamamoto J, Shimada K, Inoue K, et al. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas. Cancer. 1996;77:2240–5.

    Article  PubMed  CAS  Google Scholar 

  12. Shimada K, Sakamoto Y, Sano T, Kosuge T. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery. 2006;139:288–95.

    Article  PubMed  Google Scholar 

  13. Sperti C, Pasquali C, Pedrazzoli S. Ductal adenocarcinoma of the body and tail of the pancreas. J Am Coll Surg. 1997;185:255–9.

    PubMed  CAS  Google Scholar 

  14. Han SL, Zhang WJ, Zheng XF, Shen X, et al. Radical resection and outcome for malignant tumors of the pancreatic body and tail. World J Gastroenterol. 2009;15:5346–51.

    Article  PubMed  Google Scholar 

  15. Yeo CJ, Cameron JL, Lilemore KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas, 201 patients. Ann Surg. 1995;221:721–31.

    Article  PubMed  CAS  Google Scholar 

  16. Nagakawa T, Nagamori M, Futakami F, Tsukioka Y, Kayahara M, Ohta T, et al. Results of extensive surgery for pancreatic carcinoma. Cancer. 1996;77:640–5.

    Article  PubMed  CAS  Google Scholar 

  17. Nakao A, Harada T, Nonami T, Kaneko S, Nomoto H, Koyama K, et al. Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg. 1997;84:1090–2.

    Article  PubMed  CAS  Google Scholar 

  18. Dalton RR, Sarr MG, van Heerden JA, Colby TV. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery. 1992;111:489–94.

    PubMed  CAS  Google Scholar 

  19. Nordback IH, Hruban RH, Boitnott JK, et al. Carcinoma of the body and tail of the pancreas. Am J Surg. 1992;164:26–31.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Ms. Shu-Fang Huang, Chang Gung Memorial Hospital, Taiwan for the statistical analysis.

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University, 5-Fu-Hsin road, Kwei-shan, Taoyuan, 333, Taiwan

    Vinayak S. Rohan, Jun-Te Hsu, Keng-Hao Liu, Chun-Nan Yeh, Ta-Sen Yeh, Yi-Yin Jan & Tsann-Long Hwang

Authors
  1. Vinayak S. Rohan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun-Te Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keng-Hao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chun-Nan Yeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ta-Sen Yeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi-Yin Jan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tsann-Long Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vinayak S. Rohan.

Additional information

Rohan Vinayak S and Hwang TL contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rohan, V.S., Hsu, JT., Liu, KH. et al. Long-Term Results and Prognostic Factors in Resected Pancreatic Body and Tail Adenocarcinomas. J Gastrointest Canc 44, 89–93 (2013). https://doi.org/10.1007/s12029-012-9448-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-012-9448-4

Keywords

Search

Navigation